RNF185 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
3.20129999997754E-06 |
Normal-vs-Stage3 |
3.57909999970651E-07 |
Normal-vs-Stage4 |
1.60982338570648E-14 |
Stage1-vs-Stage2 |
2.939400E-01 |
Stage1-vs-Stage3 |
2.533800E-01 |
Stage1-vs-Stage4 |
3.772400E-02 |
Stage2-vs-Stage3 |
9.834000E-01 |
Stage2-vs-Stage4 |
1.789980E-02 |
Stage3-vs-Stage4 |
2.576400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
1.62470037423645E-12 |
Normal-vs-Asian |
4.199900E-02 |
Caucasian-vs-AfricanAmerican |
5.723800E-01 |
Caucasian-vs-Asian |
6.526800E-01 |
AfricanAmerican-vs-Asian |
5.823200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
6.66133814775094E-16 |
Male-vs-Female |
2.440400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.63880020664919E-12 |
Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
Normal-vs-Obese |
1.63657976059994E-12 |
Normal-vs-Extreme_Obese |
8.46450000000498E-05 |
Normal_Weight-vs-Extreme_Weight |
8.014200E-01 |
Normal_Weight-vs-Obese |
7.291700E-02 |
Normal_Weight-vs-Extreme_Obese |
7.357800E-01 |
Extreme_Weight-vs-Obese |
5.013700E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.079600E-01 |
Obese-vs-Extreme_Obese |
4.555800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.59529999502695E-08 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.92001969878675E-12 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.830600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.680200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.977000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.032400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.537200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.448000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
Normal-VS-Type2 PRCC |
2.96951352396491E-12 |
Normal-VS-KIRP CIMP |
9.68550000000068E-05 |
Normal-VS-Unclassified PRCC |
1.54509738337083E-11 |
Type1 PRCC-VS-Type2 PRCC |
2.448000E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.192570E-01 |
Type1 PRCC-VS-Unclassified PRCC |
6.793600E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.313390E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.050000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.416170E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.83737527601625E-13 |
Normal-vs-N1 |
3.4939995341432E-10 |
Normal-vs-N2 |
5.488000E-02 |
N0-vs-N1 |
2.807400E-01 |
N0-vs-N2 |
5.545000E-01 |
N1-vs-N2 |
9.116800E-01 |
|
|